David A. Siegel Annexon, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Annexon, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 17,400 shares of ANNX stock, worth $48,023. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,400
Previous 37,200
53.23%
Holding current value
$48,023
Previous $220,000
59.55%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding ANNX
# of Institutions
156Shares Held
98.2MCall Options Held
146KPut Options Held
174K-
Satter Management Co., L.P.7.41MShares$20.4 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$19.3 Million1.34% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$18.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA6.3MShares$17.4 Million2.53% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.63MShares$15.5 Million0.07% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $131M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...